TransOral Pharmaceuticals Raises $40M
Pt. Richmond-based TransOral Pharmaceuticals said Tuesday that it has raised $40M in a Series D funding. The funding came from New Enterprise Associates, which led the round, and also included New Leaf Venture Partners, Montreux Equity Partners, InterWest Partners, Hamilton BioVentures, Vivo Ventures, and Peninsula Equity Partners. The funding will go towards development of the firm's treatment for insomnia.
posted on Tuesday, March 6, 2007 (Link to more information)
Related companies:
TransOral Pharmaceuticals
Related stories:
> Bridge Pharmaceuticals Raises $35M
> MicuRx Raises $10M
> Third Rock Ventures Raises $426M Fund, Sets Up Shop In San Francisco
> MAP Pharmaceuticals Raises $50M
> Anthera Pharmaceuticals Raises $36M
silicontap.com Home